ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

ASN / Education & Meetings / Kidney Week /

Autosomal Dominant Polycystic Kidney Disease: 2026 Clinical Updates

Autosomal Dominant Polycystic Kidney Disease: 2026 Clinical Updates

October 21, 2026 | 07:00 AM - 06:00 PM

Location: Room TBD, Convention Center

Session Description

ADPKD, the most common hereditary kidney disorder, is the fourth leading cause of ESKD and can cause life-threatening extrarenal manifestations. This program provides a comprehensive, case-based update on key aspects of ADPKD care, including the context of the 2025 KDIGO ADPKD guideline.

ASN designates this live activity for a maximum of 7.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Session Objectives

Upon completion of this program, the participant will be able to: 1) describe the approach to ADPKD diagnosis, classification, and prognosis prediction; 2) discuss renal and extrarenal manifestations of ADPKD and their management; 3) explain current pharmacologic approaches and supportive care for ADPKD; and 4) identify strategies for holistic ADPKD patient-centered care.

ASN thanks the PKD Foundation for assistance with this program.

Moderators

Presentations